Cargando…

FTI-277 inhibits smooth muscle cell calcification by up-regulating PI3K/Akt signaling and inhibiting apoptosis

BACKGROUND: Vascular calcification is associated with increased cardiovascular morbidity and mortality in patients with atherosclerosis, diabetes and chronic kidney disease. However, no viable treatments for this condition have been identified. This study aimed to determine whether farnesyl transfer...

Descripción completa

Detalles Bibliográficos
Autores principales: Ponnusamy, Arvind, Sinha, Smeeta, Hyde, Gareth D., Borland, Samantha J., Taylor, Rebecca F., Pond, Emma, Eyre, Heather J., Inkson, Colette A., Gilmore, Andrew, Ashton, Nick, Kalra, Philip A., Canfield, Ann E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916518/
https://www.ncbi.nlm.nih.gov/pubmed/29689070
http://dx.doi.org/10.1371/journal.pone.0196232
_version_ 1783317025186119680
author Ponnusamy, Arvind
Sinha, Smeeta
Hyde, Gareth D.
Borland, Samantha J.
Taylor, Rebecca F.
Pond, Emma
Eyre, Heather J.
Inkson, Colette A.
Gilmore, Andrew
Ashton, Nick
Kalra, Philip A.
Canfield, Ann E.
author_facet Ponnusamy, Arvind
Sinha, Smeeta
Hyde, Gareth D.
Borland, Samantha J.
Taylor, Rebecca F.
Pond, Emma
Eyre, Heather J.
Inkson, Colette A.
Gilmore, Andrew
Ashton, Nick
Kalra, Philip A.
Canfield, Ann E.
author_sort Ponnusamy, Arvind
collection PubMed
description BACKGROUND: Vascular calcification is associated with increased cardiovascular morbidity and mortality in patients with atherosclerosis, diabetes and chronic kidney disease. However, no viable treatments for this condition have been identified. This study aimed to determine whether farnesyl transferase inhibitors (FTIs) can reduce vascular calcification and the mechanism by which this reduction occurs. RESULTS: We demonstrate that FTI-277 significantly inhibits phosphate-induced mineral deposition by vascular smooth muscle cells (VSMC) in vitro, prevents VSMC osteogenic differentiation, and increases mRNA expression of matrix Gla protein (MGP), an inhibitor of mineralization. FTI-277 increases Akt signaling in VSMC in short-term serum-stimulation assays and in long-term mineralization assays. In contrast, manumycin A has no effect on Akt signaling or mineralization. Co-incubation of VSMC with FTI-277 and SH6 (an Akt inhibitor) significantly reduces the inhibitory effect of FTI-277 on mineralization, demonstrating that FTI-277 inhibits calcification by activating Akt signaling. Over-expression of the constitutively active p110 sub-unit of PI3K in VSMC using adenovirus activates Akt, inhibits mineralization, suppresses VSMC differentiation and significantly enhances MGP mRNA expression. FTI-277 also inhibits phosphate-induced activation of caspase 3 and apoptosis of VSMC, and these effects are negated by co-incubation with SH6. Finally, using an ex vivo model of vascular calcification, we demonstrate that FTI-277 inhibits high phosphate-induced mineralization in aortic rings derived from rats with end-stage renal failure. CONCLUSIONS: Together, these results demonstrate that FTI-277 inhibits VSMC mineral deposition by up-regulating PI3K/Akt signaling and preventing apoptosis, suggesting that targeting farnesylation, or Akt specifically, may have therapeutic potential for the prevention of vascular calcification.
format Online
Article
Text
id pubmed-5916518
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-59165182018-05-05 FTI-277 inhibits smooth muscle cell calcification by up-regulating PI3K/Akt signaling and inhibiting apoptosis Ponnusamy, Arvind Sinha, Smeeta Hyde, Gareth D. Borland, Samantha J. Taylor, Rebecca F. Pond, Emma Eyre, Heather J. Inkson, Colette A. Gilmore, Andrew Ashton, Nick Kalra, Philip A. Canfield, Ann E. PLoS One Research Article BACKGROUND: Vascular calcification is associated with increased cardiovascular morbidity and mortality in patients with atherosclerosis, diabetes and chronic kidney disease. However, no viable treatments for this condition have been identified. This study aimed to determine whether farnesyl transferase inhibitors (FTIs) can reduce vascular calcification and the mechanism by which this reduction occurs. RESULTS: We demonstrate that FTI-277 significantly inhibits phosphate-induced mineral deposition by vascular smooth muscle cells (VSMC) in vitro, prevents VSMC osteogenic differentiation, and increases mRNA expression of matrix Gla protein (MGP), an inhibitor of mineralization. FTI-277 increases Akt signaling in VSMC in short-term serum-stimulation assays and in long-term mineralization assays. In contrast, manumycin A has no effect on Akt signaling or mineralization. Co-incubation of VSMC with FTI-277 and SH6 (an Akt inhibitor) significantly reduces the inhibitory effect of FTI-277 on mineralization, demonstrating that FTI-277 inhibits calcification by activating Akt signaling. Over-expression of the constitutively active p110 sub-unit of PI3K in VSMC using adenovirus activates Akt, inhibits mineralization, suppresses VSMC differentiation and significantly enhances MGP mRNA expression. FTI-277 also inhibits phosphate-induced activation of caspase 3 and apoptosis of VSMC, and these effects are negated by co-incubation with SH6. Finally, using an ex vivo model of vascular calcification, we demonstrate that FTI-277 inhibits high phosphate-induced mineralization in aortic rings derived from rats with end-stage renal failure. CONCLUSIONS: Together, these results demonstrate that FTI-277 inhibits VSMC mineral deposition by up-regulating PI3K/Akt signaling and preventing apoptosis, suggesting that targeting farnesylation, or Akt specifically, may have therapeutic potential for the prevention of vascular calcification. Public Library of Science 2018-04-24 /pmc/articles/PMC5916518/ /pubmed/29689070 http://dx.doi.org/10.1371/journal.pone.0196232 Text en © 2018 Ponnusamy et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Ponnusamy, Arvind
Sinha, Smeeta
Hyde, Gareth D.
Borland, Samantha J.
Taylor, Rebecca F.
Pond, Emma
Eyre, Heather J.
Inkson, Colette A.
Gilmore, Andrew
Ashton, Nick
Kalra, Philip A.
Canfield, Ann E.
FTI-277 inhibits smooth muscle cell calcification by up-regulating PI3K/Akt signaling and inhibiting apoptosis
title FTI-277 inhibits smooth muscle cell calcification by up-regulating PI3K/Akt signaling and inhibiting apoptosis
title_full FTI-277 inhibits smooth muscle cell calcification by up-regulating PI3K/Akt signaling and inhibiting apoptosis
title_fullStr FTI-277 inhibits smooth muscle cell calcification by up-regulating PI3K/Akt signaling and inhibiting apoptosis
title_full_unstemmed FTI-277 inhibits smooth muscle cell calcification by up-regulating PI3K/Akt signaling and inhibiting apoptosis
title_short FTI-277 inhibits smooth muscle cell calcification by up-regulating PI3K/Akt signaling and inhibiting apoptosis
title_sort fti-277 inhibits smooth muscle cell calcification by up-regulating pi3k/akt signaling and inhibiting apoptosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916518/
https://www.ncbi.nlm.nih.gov/pubmed/29689070
http://dx.doi.org/10.1371/journal.pone.0196232
work_keys_str_mv AT ponnusamyarvind fti277inhibitssmoothmusclecellcalcificationbyupregulatingpi3kaktsignalingandinhibitingapoptosis
AT sinhasmeeta fti277inhibitssmoothmusclecellcalcificationbyupregulatingpi3kaktsignalingandinhibitingapoptosis
AT hydegarethd fti277inhibitssmoothmusclecellcalcificationbyupregulatingpi3kaktsignalingandinhibitingapoptosis
AT borlandsamanthaj fti277inhibitssmoothmusclecellcalcificationbyupregulatingpi3kaktsignalingandinhibitingapoptosis
AT taylorrebeccaf fti277inhibitssmoothmusclecellcalcificationbyupregulatingpi3kaktsignalingandinhibitingapoptosis
AT pondemma fti277inhibitssmoothmusclecellcalcificationbyupregulatingpi3kaktsignalingandinhibitingapoptosis
AT eyreheatherj fti277inhibitssmoothmusclecellcalcificationbyupregulatingpi3kaktsignalingandinhibitingapoptosis
AT inksoncolettea fti277inhibitssmoothmusclecellcalcificationbyupregulatingpi3kaktsignalingandinhibitingapoptosis
AT gilmoreandrew fti277inhibitssmoothmusclecellcalcificationbyupregulatingpi3kaktsignalingandinhibitingapoptosis
AT ashtonnick fti277inhibitssmoothmusclecellcalcificationbyupregulatingpi3kaktsignalingandinhibitingapoptosis
AT kalraphilipa fti277inhibitssmoothmusclecellcalcificationbyupregulatingpi3kaktsignalingandinhibitingapoptosis
AT canfieldanne fti277inhibitssmoothmusclecellcalcificationbyupregulatingpi3kaktsignalingandinhibitingapoptosis